Gender differences in disability and health-related quality of life in patients with Parkinson's disease treated with stereotactic surgery

Acta Neurologica Scandinavica

Volumn 108, Issue 1, 2003, Pages 28-37

  Hariz, Gun Marie ^a   Lindberg, Margareta ^a   Hariz, Marwan I ^a   Bergenheim, A Tommy ^a  

^a UMEÅ UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Activities of daily living; Deep brain stimulation; Disability; Gender; Health related quality of life; Pallidotomy; Parkinson's disease

Indexed keywords

ACTIVITIES OF DAILY LIVING TAXONOMY; ADULT; AGED; ARTICLE; BRAIN DEPTH STIMULATION; DAILY LIFE ACTIVITY; DISABILITY; DISEASE DURATION; EMOTION; FEMALE; GLOBUS PALLIDUS; HEALTH STATUS; HUMAN; LIFE SATISFACTION; LIFE SATISFACTION QUESTIONNAIRE; MAJOR CLINICAL STUDY; MALE; NOTTINGHAM HEALTH PROFILE; PALLIDOTOMY; PARKINSON DISEASE; QUALITY OF LIFE; RATING SCALE; SEX DIFFERENCE; SOCIAL LIFE; STEREOTAXIC SURGERY; SUBTHALAMIC NUCLEUS; THALAMOTOMY; THALAMUS; UNIFIED PARKINSON DISEASE RATING SCALE; VISUAL ANALOG SCALE;

AGED; AGED, 80 AND OVER; DISABILITY EVALUATION; FEMALE; FOLLOW-UP STUDIES; HEALTH STATUS; HUMANS; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PARKINSON DISEASE; POSTOPERATIVE PERIOD; PROSPECTIVE STUDIES; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX; SEX FACTORS; STEREOTAXIC TECHNIQUES;

EID: 0038723539     PISSN: 00016314     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0404.2003.00092.x     Document Type: Article

References (45)

1. HALLET M, LITVAN I, and the Task Force on Surgery for Parkinons's Disease. Evaluation of surgery for Parkinson's disease: a report of the therapeutics and technology assessment subcommittee of the American Academy of Neurology. Neurology 1999;53:1910-21.
2. HARIZ G-M, HARIZ MI. Gender distribution in surgery for Parkinson's disease. Parkinsonism Relat Disord 2000;6:155-7.
3. FAHN S, ELTON RL, and Members of the UPDRS Development Committee. Unified Parkinson's Disease Rating Scale. In: FAHN S, MARSDEN CD, CALNE DB, GOLDSTEIN M, eds. Recent developments in Parkinson's disease. Florham Park, NJ: Macmillan Healthcare Information, 1987;153-63.
4. TÖRNQUIST K, SONN U. Towards an ADL taxonomy for occupational therapists. Scand J Occup Ther 1994;1:69-76.
5. HUNT SM, MCEWEN J, MCKENNA SP. Measuring health status: a new tool for clinicians and epidemiologists. J Coll Gen Pract 1985;35:185-8.
6. WIKLUND I. The Nottingham Health Profile - a measure of health-related quality of life. Scand J Prim Health Care Suppl 1990;1:15-18.
7. FUGL-MEYER AR, BRÄNHOLM I-B, FUGL-MEYER KS. Happiness and domain-specific life satisfaction in adult northern Swedes. Clin Rehabil 1991;5:25-33.
8. BRÄNHOLM I-B, ERHARDSSON M. On life satisfaction and activity preferences in subjects with multiple sclerosis: a comparative study. Scand J Occup Ther 1994;1:17-23.
9. CLARKE PRF, SPEAR FG. Reliability and sensitivity in the self-assessment of well-being [abstract]. Bull Br Psychol Soc 1964;17,55:18A.
10. HUSKISSON EC. Measurement of pain. Lancet 1974;2:1127-31.
11. FAVRE J, BURCHIEL KJ, TAHA JM, HAMMERSTAD J. Outcome of unilateral and bilateral pallidotomy for Parkinson's disease: patient assessment. Neurosurgery 2000;46:344-55.
12. FOLSTEIN MF, FOLSTEIN SE, MCHUGH PR. 'Mini-Mental State': a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-98.
13. HARIZ MI, SHAMSGOVARA P, JOHANSSON F, HARIZ G-M, FODSTAD H. Tolerance and tremor rebound following long-term chronic thalamic stimulation for Parkinsonian and essential tremor. Stereotact Funct Neurosurg 1999;72:208-18.
14. FILLENBAUM G, HEYMAN A, WILLIAMS K, PROSNITZ B, BURCHETT B. Sensitivity and specificity of standardized screens of cognitive impairment and dementia among elderly black and white community residents. J Clin Epidemiol 1990;43:651-60.
15. HARIZ G-M, LINDBERG M, BERGENHEIM AT. Impact of thalamic deep brain stimulation on disability and health related quality of life in patients with essential tremor. J Neurol Neurosurg Psychiatry 2002;72:47-52.
16. HUNT SM, MCEWEN J. The development of a subjective health indicator. Sociol Health Illness 1980;2:231-46.
17. HERLOFSON KARLSEN K, LARSEN JP, TANDBERG E, MÆLAND JG. Influence of clinical and demographic variables on quality of life in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry 1999;66:431-5.
18. MARTÍNEZ-MARTÍN P, GRANDAS F, LINAZASORO G, BRAVO JL and the STAR study Group. Conversion to controlled-release levodopa/carbidopa treatment and quality of life as measured by the Nottingham Health Profile. Neurologia 1999;14:338-43.
19. HAGELL P, CRABB L, POGARELL O et al. Health-related quality of life following bilateral intrastriatal transplantation in Parkinson's disease. Mov Disord 2000;15:224-9.
20. FUGL MEYER KS. Hälsa, sexuell förmålga och livskvalité. In: Lewin B, ed. Sex i Sverige, om sexuallivet i Sverige 1996. Folkhälsoinstitutet, Stockholm: PRINTUS, 1997;219-33.
21. HARIZ MI, JOHANSSON F, SHAMSGOVARA P, JOHANSSON E, HARIZ G-M, FAGERLUND M. Bilateral subthalamic nucleus stimulation in a Parkinsonian patient with preoperative deficits in speech and cognition: persistent improvement in mobility but increased dependency. A case study. Mov Disord 2000;15:136-9.
22. KRACK P, POLLAK P, LIMOUSIN P et al. Subthalamic nucleus or internal pallidal stimulation in young onset Parkinson's disease. Brain 1998;121:451-7.
23. SCOTT B, BORGMAN A, ENGLER H, JOHNELS B, AQUILONIUS SM. Gender differences in Parkinson's disease symptom profile. Acta Neurol Scand 2000;102:37-43.
24. HELY MA, MORRIS JGL, REID WGJ et al. Age at onset: the major determinant of outcome in Parkinson's disease. Acta Neurol Scand 1995;92:455-63.
25. Parkinson Study Group. Impact of deprenyl and tocopherol treatment on Parkinson's disease in DATATOP patients requiring levodopa. Ann Neurol 1996;39:37-45.
26. LYONS KE, HUBBLE JP, TRÖSTER AI, PAHWA R, KOLLER WC. Gender differences in Parkinson's disease. Clin Neuropharmacol 1998;21:118-21.
27. BERZON RA. Understanding and using health-related quality of life instruments within clinical research studies. In: SPILKER B, ed. Quality of life and pharmacoeconomics in clinical trials, 2nd edn. Oxford: Oxford University Press, 1998:3-15.
28. LEPLÉGE A, HUNT S. The problem of quality of life in medicine. J Am Med Assoc 1997;278:47-50.
29. WARD CD. What contributes to quality of life in patients with Parkinson's disease? J Neurol Neurosurg Psychiatry 2000;69:289-90.
30. SHUMAKER SA, NAUGHTON MJ. The international assessment of health-related quality of life: a theoretical perspective. In: SHUMAKER SA, BERZON R, eds. The international assessments of health-related quality of life: theory, translation, measurement and analysis. Oxford: Rapid Communications of Oxford Ltd, 1995:3-10.
31. LEVEILLE SG, RESNICK HE, BALFOUR J. Gender differences in disability: evidence and underlying reasons. Aging Clin Exp Res 2000;12:106-12.
32. FREYD M. The graphic rating scale. J Educ Psychol 1923;14:83-102.
33. PETO V, JENKINSON C, FITZPATRICK R, GREENHALL R.The development and validation of a short measure of functioning and well being for individuals with Parkinson's disease. Qual Life Res 1995;4:241-8.
34. DE BOER AGEM, WIJKER W, SPEELMAN JD, DE HAES JCJM. Quality of life in patients with Parkinson's disease: development of a questionnaire. J Neurol Neurosurg Psychiatry 1996;61:70-4.
35. CALNE S, SCHULZER M, MAK E et al. Validating a quality of life rating scale for idiopathic Parkinsonism: Parkinson's Impact Scale (PIMS). Parkinsonism Relat Disord 1996;2:55-61.
36. D'ANTONIO LL, ZIMMERMAN GJ, IACONO RP. Changes in health related quality of life in patients with Parkinson's disease with and without posteroventral pallidotomy. Acta Neurochir 2000;142:759-68.
37. MEYERS AR, GAGE H, HENDRICKS A. Health-related quality of life in neurology. Arch Neurol 2000;57:1224-7.
38. MERRILL SS, SEEMAN TE, KASL SV, BERKMAN LF. Gender differences in the comparison of self-reported disability and performance measures. J Gerontol Med Sci 1997;52A: M19-M26.
39. BROWN RG, MACCARTHY B, JAHANSHAHI M, MARSDEN CD. Accuracy of self-reported disability in patients with Parkinsonism. Arch Neurol 1989;46:955-9.
40. Council on Ethical and Judicial Affairs, American Medical Association. Gender disparities in clinical decision making. J Am Med Assoc 1991;266:559-62.
41. TANNER CM. Epidemiology of Parkinson's disease. Neurol Clin 1992;10:317-29.
42. ROMÁN GC, ZHANG Z-X, ELLENBERG JH. The neuroepidemiology of Parkinson's disease. In: ELLENBERG JH, KOLLER WC, LANGSTON JW, eds. Etiology of Parkinson's disease. New York: Marcel Dekker Inc., 1995;203-43.
43. ELLENBERG JH. Early life and demographic factors predisposing to Parkinson's disease. In: ELLENBERG JH, KOLLER WC, LANGSTON JW, eds. Etiology of Parkinson's disease. New York: Marcel Dekker Inc., 1995;277-94.
44. DE RIJK MC, TZOURIO C, BRETELER MMB et al. for the EUROPARKINSON study group. Prevalence of parkinsonism and Parkinson's disease in Europe: the EUROPARKINSON Collaborative Study. J Neurol Neurosurg Psychiatry 1997;62:10-15.
45. HAMMARSTRÖM A, RIPPER M. What could a feminist perspective on power bring into public health? Scand J Public Health 1999;27:286-9.